Krystal Biotech, Inc. - Common Stock (KRYS)

Krystal Biotech, Inc. (NASDAQ: KRYS) is one of today’s top gainers. The company’s shares have moved 35.6% on the day to $150.96.

Karen Sims, MD, PhD Promoted to Chief Medical Officer

Krystal Biotech, Inc. (NASDAQ: KRYS) is the focus of IBN’s latest stock spotlight. The company’s shares have moved 0.59% on the day to $128.12.

Regulatory momentum, bullish Wall Street analysts and favorable technicals all suggest Krystal Biotech, Inc. may be a gem.

Company to Deliver to Patients FDA-Approved Topical Treatment for Dystrophic Epidermolysis Bullosa (DEB)

Krystal Biotech, Inc. (NASDAQ: KRYS) has caught the attention of the investment community today with its bullish price action. The company’s shares are currently up 15.72% on the day to $111.16.